Multilayer collagen-based membrane

JP2023553217A5Pending Publication Date: 2024-11-19OSTEOGENICS BIOMEDICAL INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
JP2023559970
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Priority Date
2020-12-11
Filing Date
2021-12-09
Publication Date
2024-11-19

AI Technical Summary

Technical Problem

Existing collagen-based membranes for tissue regeneration face challenges such as thickness and size limitations, handleability issues, and delamination, which can lead to infection and tissue damage, particularly in dynamic healing environments like the maxillofacial region.

Method used

A multilayered collagen-based membrane is developed with a bioabsorbable mesh embedded between decellularized collagen membranes, crosslinked to enhance stability and strength, using methods that avoid adhesives and ensure uniform absorption rates, and incorporating UV cross-linking to prevent delamination.

Benefits of technology

The multilayered membrane achieves enhanced stability and strength, preventing delamination and ensuring consistent absorption, thereby supporting predictable healing and reducing infection risks.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader

Abstract

The present invention provides a multilayer collagen-based membrane comprising a bioabsorbable mesh embedded between a first decellularized native collagen-based membrane and a second decellularized native collagen-based membrane. The bioabsorbable mesh can be formed from a synthetic polymer or demineralized lamellar bone. Two methods for producing the multilayer collagen-based membrane, with or without the embedded bioabsorbable mesh, are also provided.
Need to check novelty before this filing date? Find Prior Art

Description

Background Art

[0001] Collagen is widely used as a biomaterial in the surgical field and has a long history of use in the specific area of tissue regeneration. For example, Patent Documents 1 and 2 each describe a single-layer collagen device for tissue regeneration. Collagen devices can be designed and formed from reconstituted collagen. Alternatively, collagen devices can be of natural origin, i.e., manufactured from tissues collected in their natural state and processed without significantly changing the physical dimensions of the tissue for use as a biomaterial. One drawback of collagen devices derived from natural tissues is that the thickness and overall size of the final device are determined by the target tissue. Therefore, strategies for changing the thickness and size have been developed. See Patent Documents 3 and 4.

[0002] Another strategy for changing the physical and mechanical properties of collagen devices is reinforcement. By combining a second biomaterial with collagen, it is possible to improve the strength or handling properties of the device while maintaining the biological advantages of collagen. For example, Patent Document 5 describes laminating collagen and a second biocompatible mesh by lamination, compression, and drying.

[0003] In clinical tissue regeneration procedures, especially in the craniofacial region where the host tissue moves significantly during the healing stage, stability is required for predictable healing. Any delamination of the laminated device typically creates dead space within the wound and may contribute to infection and treatment failure. Delamination can also lead to loss of stability of the reinforcing element and lead to compatibility problems that can cause tissue perforation and damage. Therefore, in laminated devices, the stability and lifespan of the lamination are of utmost importance.

[0004] While the use of naturally derived collagen membranes in various hard and soft tissue regeneration procedures offers advantages, achieving an ideal configuration for clinical use may require modifications to the inherent limitations of the source tissue, namely thickness, handling characteristics, and overall size. It would be advantageous to be able to link several collagen sheets together, modify their overall thickness, or laminate them with interposed components. Furthermore, for clinical success, the strength of the lamination must be sufficiently resilient to delamination when wetted with bodily fluids.

[0005] A collagen-based membrane having multiple layers that does not have the aforementioned drawbacks is needed. [Prior art documents] [Patent Documents]

[0006] [Patent Document 1] U.S. Patent No. 5206028 [Patent Document 2] U.S. Patent No. 5837278 [Patent Document 3] U.S. Patent No. 5955110 [Patent Document 4] U.S. Patent No. 5885619 [Patent Document 5] U.S. Patent Application Publication No. 2014 / 0067058 [Overview of the project]

[0007] To meet this need, a multilayer collagen-based membrane is provided, which includes a bioabsorbable mesh embedded between a first decellularized natural collagen-based membrane and a second decellularized natural collagen-based membrane. The first decellularized natural collagen-based membrane and the second decellularized natural collagen-based membrane are crosslinked with each other, and the multilayer collagen-based membrane has a 90° peel strength of 5 N / m to 250 N / m.

[0008] A method for producing a multilayer collagen-based membrane is also provided. This method involves obtaining a first decellularized natural collagen-containing membrane and a second decellularized natural collagen-containing membrane, placing the second decellularized natural collagen-containing membrane on the first decellularized natural collagen-containing membrane to form a membrane assembly, drying the membrane assembly under weights evenly distributed throughout the membrane assembly and containing openings for moisture release, and exposing the membrane assembly to a crosslinking agent so that crosslinks are formed between the layers of the membrane assembly. Each layer of the multilayer collagen-based membrane is absorbed at essentially the same rate upon in vivo implantation, and no adhesives are used in the process.

[0009] A second method for producing a multilayer collagen-based membrane is also disclosed. This method includes the steps of: obtaining a first dried decellularized natural collagen-containing membrane and a second dried decellularized natural collagen-containing membrane; obtaining a bioabsorbable synthetic polymer mesh; placing the bioabsorbable synthetic polymer mesh on the first dried decellularized natural collagen-containing membrane; hydrating the first dried decellularized natural collagen-containing membrane to form a first hydrated membrane; placing the second dried decellularized natural collagen-containing membrane on the bioabsorbable synthetic polymer mesh such that the second dried decellularized natural collagen-containing membrane is hydrated by removing water from the first hydrated membrane; drying the membrane mesh assembly under weights evenly distributed throughout the entire membrane mesh assembly; and exposing the dried membrane mesh assembly to a crosslinking agent such that crosslinks are formed between the layers of the membrane mesh assembly. In this second method, similar to the first method, each layer is absorbed in vivo at essentially the same rate, and the bioabsorbable synthetic polymer mesh imparts shape memory to the multilayer collagen-based membrane, forming a multilayer collagen-based membrane without the use of adhesives in the process.

[0010] Details of one or more embodiments are described in the following description and examples. Other features, purposes, and advantages will become apparent from the detailed description, drawings, and appended claims.

[0011] Please refer to the attached drawings for further details. [Brief explanation of the drawing]

[0012] [Figure 1] This is a diagram of the multilayer collagen-based membrane of the present invention. [Figure 2] This is a flowchart of the manufacturing process for creating multilayer collagen-based membranes. [Figure 3] This figure shows an exemplary method for manufacturing a multilayer collagen-based membrane and its clinical applications according to the present invention. 1, 3 = Collagen-based membrane; 2 = Bioabsorbable mesh; 4 = Multilayer collagen membrane assembly; 5 = UV crosslinking device; 6 = Finished multilayer collagen-based membrane; 7 = Finished multilayer collagen-based membrane used to cover a forearm wound. [Modes for carrying out the invention]

[0013] As summarized above, the multilayer collagen-based membrane of the present invention includes a bioabsorbable mesh embedded between a first decellularized natural collagen-based membrane and a second decellularized natural collagen-based membrane. In the exemplary multilayer collagen-based membrane, the bioabsorbable mesh does not extend to the edges of the multilayer collagen-based membrane, leaving a bioabsorbable mesh-free rim around the edges.

[0014] Bioabsorbable meshes can be formed from demineralized layered bone. The layered bone can be from mammals, such as humans, cattle, sheep, horses, and pigs. The demineralized layered bone may take the form of a mesh, for example, formed by die-cutting or laser-cutting.

[0015] In alternative multilayer collagen-based membranes, the bioabsorbable mesh is a synthetic polymer mesh that imparts shape memory to the multilayer collagen-based membrane. The synthetic polymer mesh can be formed from homopolymers. Examples of homopolymers include, but are not limited to, polylactide ("PLA"), polyglycolide ("PGA"), polycaprolactone ("PCL"), and trimethylene carbonate ("PTMC"). Alternatively, the synthetic polymer mesh can be formed from copolymers of monomers contained in the above-mentioned polymers, such as poly(lactic acid-co-glycolic acid) ("PLGA") and poly(lactide-co-ε-caprolactone) ("PLCL"). In certain embodiments, specific enantiomers can be used in the homopolymer or copolymer. For example, polymers such as poly(L-lactide) ("PLLA"), poly(D-lactide) ("PDLA"), or poly(DL-lactide) ("PDLLA") can be used in the synthetic polymer mesh.

[0016] Synthetic polymer meshes can be manufactured, for example, by laser cutting, die cutting, compression molding, 3D printing, and extrusion molding.

[0017] An exemplary multilayer collagen-based membrane has a synthetic polymer mesh formed from PLGA with a monomer ratio of lactic acid to glycolic acid of 25:75 to 75:25. In a specific multilayer collagen-based membrane, the monomer ratio of lactic acid to glycolic acid is 50:50. In another example, the multilayer collagen-based membrane has a synthetic polymer mesh formed from PLCL with a monomer ratio of lactic acid to caprolactone monomer of 70:30.

[0018] In certain specific multi-layer collagen-based membranes, the synthetic polymer mesh also contains calcium minerals. The calcium minerals can be calcium phosphate, β-tricalcium phosphate, calcium sulfate, hydroxyapatite, and calcium apatite derived from natural bone minerals, but are not limited thereto. The calcium minerals may contain additives such as fluorine (e.g., fluoroapatite) and magnesium.

[0019] In another multi-layer collagen-based membrane, the synthetic polymer mesh contains recombinant growth factors such as rhPDGF-BB, rhBMP-2 and FGFs. Instead of or together with them, pharmaceuticals such as antibiotics and anti-inflammatory agents may also be contained in the synthetic polymer mesh.

[0020] As described above, the multi-layer collagen-based membrane includes a first decellularized natural collagen-based membrane and a second decellularized natural collagen-based membrane The first decellularized natural collagen-containing membrane, the second decellularized natural collagen-containing membrane, or both of them are derived from the natural pericardium and have a fibrous surface and a serosal surface. The decellularized natural collagen-containing membrane is preferably derived from the parietal pericardium of mammals such as humans, cows, sheep, horses and pigs. More preferably, the decellularized natural collagen-containing membrane is derived from the parietal pericardium of pigs.

[0021] In the multi-layer collagen-based membrane of the present invention, the fibrous surface of the first decellularized natural collagen-containing membrane can contact and crosslink with (i) the fibrous surface of the second decellularized natural collagen-containing membrane or (ii) the serosal surface of the second decellularized natural collagen-containing membrane.

[0022] In an alternative multi-layer collagen-based membrane, the serosal surface of the first decellularized natural collagen-containing membrane can contact and crosslink with (i) the fibrous surface of the second decellularized natural collagen-containing membrane or (ii) the serosal surface of the second decellularized natural collagen-containing membrane.

[0023] The multilayer collagen-based membrane of the present invention can have a 90° dry peel strength of 5 N / m to 250 N / m, for example, 5 N / m to 250 N / m, 10 N / m to 250 N / m, 20 N / m to 250 N / m, 30 N / m to 250 N / m, 40 N / m to 250 N / m, and 50 N / m to 250 N / m. The peel strength is not uniform throughout the multilayer collagen-based membrane. As described above, in certain examples, the bioabsorbable mesh does not extend to the edges of the multilayer collagen-based membrane, and these edges without the bioabsorbable mesh have the maximum dry peel strength, i.e., 50 N / m to 250 N / m. On the other hand, the region of the multilayer collagen-based membrane containing the bioabsorbable mesh has a peel strength that varies depending on the mesh shape, e.g., mesh size, e.g., 5 N / m to 250 N / m.

[0024] Two methods for producing multilayer collagen-based membranes are also summarized above.

[0025] The first method involves (i) obtaining a first decellularized natural collagen-containing membrane and a second decellularized natural collagen-containing membrane, (ii) placing the second decellularized natural collagen-containing membrane on the first decellularized natural collagen-containing membrane to form a membrane assembly, (iii) drying the membrane assembly under weights evenly distributed throughout the entire membrane assembly, and (iv) exposing the membrane assembly to a crosslinking agent so that crosslinks are formed between the layers of the membrane assembly.

[0026] The first decellularized natural collagen-containing membrane and the second decellularized natural collagen-containing membrane are derived from natural pericardium and have a fibrous surface and a serous surface. The decellularized natural collagen-containing membrane is preferably derived from the parietal pericardium of mammals, such as humans, cattle, sheep, horses, and pigs. The decellularized natural collagen-containing membrane is more preferably derived from the parietal pericardium of pigs.

[0027] In an exemplary method, the fibrous surface of a first decellularized natural collagen-containing membrane is placed in contact with the fibrous surface of a second decellularized natural collagen-containing membrane to form a membrane assembly. Alternatively, the serous surface of the first decellularized natural collagen-containing membrane is placed in contact with the fibrous surface of the second decellularized natural collagen-containing membrane to form a membrane assembly. In another example, the serous surface of the first decellularized natural collagen-containing membrane is placed in contact with the serous surface of the second decellularized natural collagen-containing membrane to form a membrane assembly.

[0028] In a particular method, a collagen gel is applied to one or both of these decellularized natural collagen-containing membranes before placing them in contact with each other. In this method, before applying the collagen gel, the decellularized natural collagen-containing membranes are first briefly dried to remove excess moisture.

[0029] Collagen gel can be prepared from the pericardium of human, bovine, sheep, horse, or pig tissue by decellularizing the tissue, followed by hydrolysis and micronization of the collagen. The concentration of collagen in the gel can be 2.5 mg / mL to 10.0 mg / mL. A concentration of 10 mg / mL is preferred.

[0030] While not bound by theory, collagen gel is thought to facilitate the assembly and lamination of decellularized natural collagen-containing membranes by increasing the collagen contact surface area between membrane layers.

[0031] After the drying process, the film assembly is subjected to an exposure process in which it is exposed to a crosslinking agent so that crosslinks are formed between the layers of the film assembly. The crosslinking agent can be, for example, a chemical crosslinking agent, ultraviolet ("UV") rays, a crosslinking enzyme, or plastic compression.

[0032] Suitable chemical crosslinking agents include, but are not limited to, glutaraldehyde or glutaraldehyde vapor, formaldehyde or formaldehyde vapor, reducing sugars such as ribose and glucose, genipin, carbodiimides such as N-(3-dimethylaminopropyl)-N'-ethylcarbodiimide and N-hydroxysuccinimide, dialdehyde starch, riboflavin with ultraviolet A radiation, imide esters such as dimethyl svelimide, dimethyl adipimide, dimethyl pimelimide and dimethyl dithiobispropionimide, acyl azides, and 4-arm polyethylene glycol succinimidyl glutarate.

[0033] Cross-linking can also be performed using enzymes, for example, transglutaminase or lysyl oxidase.

[0034] Finally, crosslinking can be performed in conjunction with plastic compression, which orients collagen fibers by applying a physical force in a unidirectional direction to the fibers before exposure to the crosslinking agent.

[0035] When using ultraviolet light as a crosslinking agent, apply 1200 mJ / m² to the top and bottom surfaces of the dried film assembly. 2 ~216,000 mJ / m 2 The exposure process is carried out by irradiating with ultraviolet light at a total energy level of 1 minute to 210 minutes. In an exemplary method, the ultraviolet light is 12,000 mJ / m³. 2 ~48000 mJ / m 2 It has an energy level, and the exposure time is 10 to 40 minutes.

[0036] In a specific method of the present invention in which the crosslinking agent is ultraviolet light, no chemical crosslinking agent is used in the exposure step.

[0037] In certain cases, the process includes removing odor compounds generated by ultraviolet light after the exposure step. The odor compounds that can be removed are volatile decomposition oxidation by-products of fatty acids, amino acids, and peptides. These compounds may be, but are not limited to, 2-methylbutanal, 3-methylbutanal, 1-heptene, 1-octene, 1-nonene, hydrogen sulfide, sulfur dioxide, mercaptomethane, dimethyl sulfide, methyl thioacetate, dimethyl disulfide, and dimethyl trisulfide.

[0038] The removal process can be carried out, for example, by washing the membrane assembly with H2O one or more times, for example, once, twice, three times, and four times, and / or by shaking the membrane assembly in an H2O bath. Prior to washing with H2O, the membrane assembly can be washed with a buffer, for example, phosphate-buffered saline ("PBS").

[0039] The above method may also include a final drying step. Drying can be carried out by air drying or vacuum drying. Drying can be carried out at 5°C to 45°C, preferably at room temperature, for 60 to 300 minutes. If vacuum drying is used, the vacuum should be 50 mTorr to 500 mTorr.

[0040] In a particular embodiment, the method also includes the step of placing a bioabsorbable mesh on the first decellularized natural collagen-containing membrane before placing the second decellularized natural collagen-containing membrane on the first decellularized natural collagen-containing membrane.

[0041] Bioabsorbable meshes were described in detail above. Bioabsorbable meshes can be, for example, synthetic polymer meshes formed from PLA, PGA, PCL, PTMC, PLLA, PDLA, PDLLA, PLGA, PLCL, or mixtures of these polymers having the monomer ratios described above.

[0042] The above method may include an additional step of adding calcium minerals, such as calcium phosphate, calcium sulfate, and hydroxyapatite, to the polymer. For example, calcium minerals can be added by immersing the polymer in a calcium mineral solution.

[0043] Alternatively, as mentioned above, bioabsorbable mesh can be formed from demineralized layered bone.

[0044] A second method for producing multilayer collagen-based membranes is also summarized above. This process involves (i) obtaining a first dried decellularized natural collagen-containing membrane, (ii) obtaining a bioabsorbable synthetic polymer mesh, (iii) placing the bioabsorbable synthetic polymer mesh on the first dried decellularized natural collagen-containing membrane, (iv) hydrating the first dried decellularized natural collagen-containing membrane to form a first hydrated membrane, (v) obtaining a second dried decellularized natural collagen-containing membrane, (vi) placing the second dried decellularized natural collagen-containing membrane on the bioabsorbable synthetic polymer mesh so that the second dried decellularized natural collagen-containing membrane is hydrated by removing water from the first hydrated membrane, (vii) drying the membrane mesh assembly under weights evenly distributed throughout the membrane mesh assembly, and (viii) exposing the dried membrane mesh assembly to a crosslinking agent so that crosslinks are formed between the layers of the membrane mesh assembly. In this second method, similar to the first method, each layer is absorbed in vivo at essentially the same rate, and the bioabsorbable synthetic polymer mesh imparts shape memory to the multilayer collagen-based membrane, forming a multilayer collagen-based membrane without the use of adhesives in the process.

[0045] The first decellularized natural collagen-containing membrane and the second decellularized natural collagen-containing membrane are, like the bioabsorbable synthetic polymer mesh, as described above in the first method. The second method, like the first method, may employ an exposure step in which a dried membrane mesh assembly is exposed to ultraviolet light at the intensity and time described above. The membrane mesh assembly formed by the second method may also be subjected to the removal and drying steps included in the first method. In certain examples of the second method in which the crosslinking agent is ultraviolet light, no chemical crosslinking agent is used in the exposure step.

[0046] The hydration process can be carried out by applying H2O to the first dried, decellularized natural collagen-containing membrane.

[0047] Alternatively, hydration can be performed by applying the aforementioned collagen gel to the first dried, decellularized natural collagen-containing membrane. Again, collagen gels prepared from human, bovine, sheep, horse, or pig pericardium can have collagen concentrations ranging from 2.5 mg / mL to 10.0 mg / mL.

[0048] The present invention encompasses variations of the two methods described above for producing multilayer collagen-based membranes, which involve crosslinking by additional means or other means, such as exposure to a chemical crosslinking agent, ultraviolet light, or crosslinking enzymes. For example, the drying step in the first and second methods can be performed so that thermal dehydration crosslinking occurs between the collagen-containing membranes of the membrane mesh assembly. In certain methods, thermal dehydration crosslinking is employed without exposure to ultraviolet light.

[0049] Without further detail, those skilled in the art will be able to make the most of the disclosures herein. Therefore, the following specific examples are merely illustrative and should be construed as not limiting the remainder of the disclosure. All publications and patent documents cited herein constitute, by reference, an integral part of this specification. [Examples]

[0050] Example 1: Process layer assembly for manufacturing a multilayer collagen-based membrane An absorbent polymer mesh, 0.22 mm (0.0085 inches) thick, formed from copolymer PLGA (with a monomer ratio of lactic acid to glycolic acid of 50:50 or 70:30), was placed on a lyophilized porcine pericardium. A sufficient amount of reverse osmosis deionized H2O was applied to the membrane until it became clear. A second lyophilized porcine pericardium was positioned so that its fibrous surface was on the fibrous surface of the first hydrated porcine pericardium, allowing the second membrane to absorb H2O from the first membrane and become hydrated. Additional H2O was added to the remaining white areas that were not sufficiently hydrated.

[0051] Pressure was applied starting from the center of the membrane to remove excess H2O from both membranes. Once the excess H2O was removed, the membranes were firmly attracted to each other.

[0052] Care was taken to avoid excessively wetting the membrane to the point where H2O accumulated around it. The integrity of the inter-membrane interfaces affects the transparency and visual uniformity of the completed multilayer collagen-based membrane. Areas with excess H2O between the membranes may not dry completely due to H2O evaporation. These areas may appear white or cloudy when dry. Furthermore, the amount of pressure applied when extruding H2O from the membrane may affect the dry thickness of the device.

[0053] The assembled pericardial layers were left to dry under a uniform, flat weight. The weight contained a grid of pores to allow the assembled pericardial layers to dry quickly. Assembled pericardial layers tend to curl or wrinkle when dried in the open air. Drying under a grid of weights allows the membrane to dry flat and helps keep the membrane sheets in contact with each other.

[0054] Furthermore, it was found that the layered membrane retained some shape memory during drying. Additionally, drying under a grid of weights was unexpectedly superior to drying the membrane by pressing it on a silicone mat for up to 24 hours. However, this process failed to sufficiently dry the pericardial layer to reduce the bioburden at transplantation to an acceptable level.

[0055] Bridge The assembled membrane, after drying, was placed in an ultraviolet chamber and crosslinked. Crosslinking the assembled membrane is essential to prevent delamination when the multilayer collagen-based membrane comes into contact with H2O during use.

[0056] The film assembly was placed 6 inches from a 75-watt bulb source of 254 nm light, i.e., ultraviolet light, for 15 minutes. The film assembly was then flipped over and the other side was exposed to the same level of ultraviolet light for another 15 minutes. This exposure time resulted in approximately 14,000 mJ / cm² of ultraviolet light being emitted from the film surface. 2 ~22000 mJ / cm² 2 Energy for the functional amount is supplied.

[0057] While not strictly theoretical, it is believed that ultraviolet light penetrates into the interior of the film assembly. To ensure the crosslinking process is as uniform as possible, the film assembly is turned inside out.

[0058] Furthermore, sufficient crosslinking can be achieved with a processing time of less than 15 minutes per side. This processing time provides the maximum amount of UV exposure that promotes crosslinking while minimizing degradation under the conditions described above.

[0059] It is important that ultraviolet light was used for crosslinking instead of more common methods such as chemical crosslinking and thermal dehydration crosslinking. Ultraviolet light is advantageous because it avoids contamination by residual chemical crosslinking agents and also avoids the denaturation seen in thermal dehydration crosslinking. Furthermore, ultraviolet light is a novel method for controlling and / or extending the absorption time of collagen-based membranes.

[0060] Furthermore, using a dedicated, controlled 110V power supply between the power source and the crosslinking agent unit can result in a more uniform and reproducible output from the ultraviolet light bulb. This is because fluctuations in the power supplied from the power grid are regulated.

[0061] Removal of unpleasant odors Ultraviolet light during the crosslinking process releases compounds with a strong, unpleasant odor, such as caprylic acid, within the pericardium. These compounds are polar and can be removed by washing with H2O multiple times in succession. Fresh H2O was flowed over the membrane assembly for 30 seconds, then placed in a tray containing 1 L of H2O and shaken in an orbital shaker for 15-20 minutes. The membrane assembly was then washed again with fresh H2O for 30 seconds.

[0062] The cleaned membrane assembly was placed on a clean silicone surface, and its ends were secured with a sufficient number of clean stainless steel rivets to ensure the assembly was flat. The membrane assembly was then allowed to air dry completely.

[0063] Vacuum drying The membrane assembly was placed in a vacuum dryer and dried at 50 mTorr and 18°C ​​for 300 minutes.

[0064] It is known that moisture can contribute to the degradation of PLGA copolymer frames. This drying process minimizes the amount of H2O in the device in order to maintain the storage life of the PLGA frame and reduce the burden on the body.

[0065] Die-cut A multilayer collagen-based membrane was assembled using a pericardial layer slightly larger than the desired dimensions of the final product. Die cutting allowed the polymer mesh to be positioned at the center of the final product by selecting the location of the die. The die's cutting edge had to rest on a transparent surface so that the polymer mesh within the device would be visible during this process.

[0066] Because it is not possible to perfectly align the edges of the original pericardium during assembly, die-cutting the product at this stage also gives the multilayer collagen-based membrane neatly aligned, straight edges.

[0067] When die-cutting a multilayer collagen-based membrane, it is necessary to flip the membrane so that the die presses in the opposite direction to any natural curl in the membrane. This is done to reduce the curl and make the multilayer collagen-based membrane appear as flat as possible.

[0068] sterile The multilayer collagen-based membrane was sterilized with ethylene oxide ("EO").

[0069] The sterilization cycle must be operated with the minimum amount of heat and moisture necessary to sterilize the multilayer collagen-based membrane for the following reasons: Firstly, moisture from the EO cycle may remain in the polymer mesh, potentially shortening its shelf life. Secondly, heat degrades the polymer mesh, also shortening its shelf life. Thirdly, excessive heat may melt the entire structure of the polymer mesh, potentially causing deformation or alteration. Finally, excessive moisture may cause wrinkles in the collagen within the multilayer collagen-based membrane.

[0070] Multilayer collagen-based membranes should not be sterilized with electron beams. This type of radiation is known to make polymer meshes brittle.

[0071] Example 2: Preparation of collagen gel Purified collagen was prepared by decellularizing porcine pericardium using conventional methods. This collagen was micronized by low-temperature cyclone milling and then digested in citrate at pH 2.0-3.2. The gel was kept cool to minimize denaturation.

[0072] To assemble the multilayer collagen-based membrane, the pH of the collagen gel was restored to a normal range of 6.8–7.2 using sodium hydroxide before use for membrane hydration. Monosodium phosphate and sodium chloride were added as needed.

[0073] Other embodiments Any feature disclosed herein can be combined in any combination. Each feature disclosed herein can be replaced by an alternative feature serving the same, equivalent, or similar purpose. Thus, unless otherwise specified, each feature disclosed is merely one example of a comprehensive set of equivalent or similar features.

[0074] From the above description, those skilled in the art will readily grasp the essential characteristics of the present invention, and will be able to adapt the invention to various uses and conditions by making various changes and modifications without departing from its spirit and scope. Therefore, other embodiments are also within the scope of the appended claims.

Claims

1. 1. A multi-layered collagen-based membrane comprising a bioabsorbable mesh embedded between a first decellularized native collagen-containing membrane and a second decellularized native collagen-containing membrane, A multi-layered collagen-based membrane, wherein the first decellularized natural collagen-containing membrane and the second decellularized natural collagen-containing membrane are crosslinked to each other, and the multi-layered collagen-based membrane has a 90° peel strength of 5 N / m to 250 N / m.

2. The multi-layered collagen-based membrane of claim 1 , wherein the bioabsorbable mesh is formed from demineralized lamellar bone.

3. The multi-layered collagen-based membrane of claim 1 , wherein the bioabsorbable mesh is a synthetic polymer mesh, the synthetic polymer mesh providing shape memory to the multi-layered collagen-based membrane.

4. 4. The multilayered collagen-based membrane of claim 3, wherein the synthetic polymer mesh is formed from a polymer selected from the group consisting of polylactide (PLA), polyglycolide (PGA), polycaprolactone (PCL), trimethylene carbonate (PTMC), poly(lactic-co-glycolic acid) (PLGA) and poly(lactide-co-ε-caprolactone) (PLCL), or a copolymer or homopolymer comprising a mixture thereof.

5. The multi-layered collagen-based membrane of claim 4, wherein the synthetic polymer mesh is formed from PLGA having a monomer ratio of lactic acid to glycolic acid of 25:75 to 75:

25.

6. The multilayered collagen-based membrane of claim 1 , wherein the first decellularized native collagen-containing membrane has a fibrous surface and a serosal surface, and the second decellularized native collagen-containing membrane also has a fibrous surface and a serosal surface.

7. The multilayered collagen-based membrane of claim 6, wherein the fibrous surface of the first decellularized native collagen-containing membrane is in contact with and crosslinked with the fibrous surface of the second decellularized native collagen-containing membrane.

8. The multilayered collagen-based membrane of claim 6, wherein the fibrous surface of the first decellularized native collagen-containing membrane is in contact with and crosslinked with the serosal surface of the second decellularized native collagen-containing membrane.

9. The multilayered collagen-based membrane of claim 6, wherein the serosal surface of the first decellularized native collagen-containing membrane is in contact with and crosslinked with the serosal surface of the second decellularized native collagen-containing membrane.